• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肿瘤微环境中的 CCL2

CCL2 in the Tumor Microenvironment.

机构信息

Division of Chronic Inflammation and Cancer, German Cancer Research Center (DKFZ), Heidelberg, Germany.

Institute of Virology, Technical University of Munich, Munich, Germany.

出版信息

Adv Exp Med Biol. 2021;1302:1-14. doi: 10.1007/978-3-030-62658-7_1.

DOI:10.1007/978-3-030-62658-7_1
PMID:34286437
Abstract

The C-C motif chemokine ligand 2 (CCL2) is a crucial mediator of immune cell recruitment during microbial infections and tissue damage. CCL2 is also frequently overexpressed in cancer cells and other cells in the tumor microenvironment, and a large body of evidence indicates that high CCL2 levels are associated with more aggressive malignancies, a higher probability of metastasis, and poorer outcomes in a wide range of cancers. CCL2 plays a role in recruiting tumor-associated macrophages (TAMs), which adopt a pro-tumorigenic phenotype and support cancer cell survival, facilitate tumor cell invasion, and promote angiogenesis. CCL2 also has direct, TAM-independent effects on tumor cells and the tumor microenvironment, including recruitment of other myeloid subsets and non-myeloid cells, maintaining an immunosuppressive environment, stimulating tumor cell growth and motility, and promoting angiogenesis. CCL2 also plays important roles in the metastatic cascade, such as creating a pre-metastatic niche in distant organs and promoting tumor cell extravasation across endothelia. Due to its many roles in tumorigenesis and metastatic processes, the CCL2-CCR2 signaling axis is currently being pursued as a potential therapeutic target for cancer.

摘要

C-C 基序趋化因子配体 2(CCL2)是微生物感染和组织损伤过程中免疫细胞募集的关键介质。CCL2 也在癌细胞和肿瘤微环境中的其他细胞中经常过表达,大量证据表明高 CCL2 水平与侵袭性更强的恶性肿瘤、更高的转移概率和更差的预后相关。CCL2 在招募肿瘤相关巨噬细胞(TAMs)方面发挥作用,TAMs 采用促肿瘤发生的表型并支持癌细胞存活,促进肿瘤细胞侵袭,并促进血管生成。CCL2 还对肿瘤细胞和肿瘤微环境具有直接的、TAM 非依赖性的影响,包括招募其他髓系细胞亚群和非髓系细胞,维持免疫抑制环境,刺激肿瘤细胞生长和迁移,并促进血管生成。CCL2 在转移级联反应中也起着重要作用,例如在远处器官中创建一个预先转移的生态位,并促进肿瘤细胞穿过内皮的外渗。由于 CCL2-CCR2 信号轴在肿瘤发生和转移过程中具有许多作用,因此目前正在将其作为癌症的潜在治疗靶点进行研究。

相似文献

1
CCL2 in the Tumor Microenvironment.肿瘤微环境中的 CCL2
Adv Exp Med Biol. 2021;1302:1-14. doi: 10.1007/978-3-030-62658-7_1.
2
Targeting of tumour-infiltrating macrophages via CCL2/CCR2 signalling as a therapeutic strategy against hepatocellular carcinoma.通过 CCL2/CCR2 信号靶向肿瘤浸润巨噬细胞作为一种治疗肝细胞癌的策略。
Gut. 2017 Jan;66(1):157-167. doi: 10.1136/gutjnl-2015-310514. Epub 2015 Oct 9.
3
Tumor-Derived C-C Motif Ligand 2 Induces the Recruitment and Polarization of Tumor-Associated Macrophages and Increases the Metastatic Potential of Bladder Cancer Cells in the Postirradiated Microenvironment.肿瘤来源的C-C基序配体2在辐射后微环境中诱导肿瘤相关巨噬细胞的募集和极化,并增加膀胱癌细胞的转移潜能。
Int J Radiat Oncol Biol Phys. 2022 Oct 1;114(2):321-333. doi: 10.1016/j.ijrobp.2022.06.054. Epub 2022 Jun 10.
4
Roles of CCL2-CCR2 Axis in the Tumor Microenvironment.CCL2-CCR2 轴在肿瘤微环境中的作用。
Int J Mol Sci. 2021 Aug 8;22(16):8530. doi: 10.3390/ijms22168530.
5
Glioma-derived CCL2 and CCL7 mediate migration of immune suppressive CCR2/CX3CR1 M-MDSCs into the tumor microenvironment in a redundant manner.胶质母细胞瘤衍生的 CCL2 和 CCL7 以冗余方式介导免疫抑制性 CCR2/CX3CR1 M-MDSC 向肿瘤微环境迁移。
Front Immunol. 2023 Jan 4;13:993444. doi: 10.3389/fimmu.2022.993444. eCollection 2022.
6
C-C chemokine receptor 4 (CCR4)-positive regulatory T cells interact with tumor-associated macrophages to facilitate metastatic potential after radiation.CC 趋化因子受体 4(CCR4)阳性调节性 T 细胞与肿瘤相关巨噬细胞相互作用,在放疗后促进转移潜能。
Eur J Cancer. 2024 Feb;198:113521. doi: 10.1016/j.ejca.2023.113521. Epub 2023 Dec 24.
7
CCL2/CCR2 Regulates the Tumor Microenvironment in HER-2/neu-Driven Mammary Carcinomas in Mice.CCL2/CCR2调节小鼠中HER-2/neu驱动的乳腺癌的肿瘤微环境。
PLoS One. 2016 Nov 7;11(11):e0165595. doi: 10.1371/journal.pone.0165595. eCollection 2016.
8
Stromal fibroblasts shape the myeloid phenotype in normal colon and colorectal cancer and induce CD163 and CCL2 expression in macrophages.基质成纤维细胞塑造正常结肠和结直肠癌中的髓样表型,并诱导巨噬细胞中 CD163 和 CCL2 的表达。
Cancer Lett. 2021 Nov 1;520:184-200. doi: 10.1016/j.canlet.2021.07.006. Epub 2021 Jul 10.
9
CCL2-CCR2 axis recruits tumor associated macrophages to induce immune evasion through PD-1 signaling in esophageal carcinogenesis.CCL2-CCR2 轴通过 PD-1 信号招募肿瘤相关巨噬细胞诱导免疫逃逸在食管癌变中。
Mol Cancer. 2020 Feb 27;19(1):41. doi: 10.1186/s12943-020-01165-x.
10
Targeting the CCL2/CCR2 Axis in Cancer Immunotherapy: One Stone, Three Birds?靶向 CCL2/CCR2 轴在癌症免疫治疗中的应用:一石三鸟?
Front Immunol. 2021 Nov 3;12:771210. doi: 10.3389/fimmu.2021.771210. eCollection 2021.

引用本文的文献

1
Fasting-mimicking diet enhances EGFR-TKI efficacy in oral cancer through dual mechanisms: direct cancer cell sensitization and tumor-associated macrophage crosstalk.模拟禁食饮食通过双重机制增强口腔癌中表皮生长因子受体酪氨酸激酶抑制剂(EGFR-TKI)的疗效:直接使癌细胞致敏和肿瘤相关巨噬细胞相互作用。
Front Pharmacol. 2025 Jul 30;16:1641024. doi: 10.3389/fphar.2025.1641024. eCollection 2025.
2
Transcriptional Repression of CCL2 by K3.1 K Channel Activation and LRRC8A Anion Channel Inhibition in THP-1-Differentiated M Macrophages.K3.1钾通道激活和LRRC8A阴离子通道抑制对THP-1分化的巨噬细胞中CCL2转录的抑制作用
Int J Mol Sci. 2025 Aug 6;26(15):7624. doi: 10.3390/ijms26157624.
3

本文引用的文献

1
Ontogeny of Tumor-Associated Macrophages.肿瘤相关巨噬细胞的发生发展。
Front Immunol. 2019 Jul 31;10:1799. doi: 10.3389/fimmu.2019.01799. eCollection 2019.
2
The Polycomb Repressor Complex 1 Drives Double-Negative Prostate Cancer Metastasis by Coordinating Stemness and Immune Suppression.多梳抑制复合物 1 通过协调干性和免疫抑制驱动双阴性前列腺癌转移。
Cancer Cell. 2019 Aug 12;36(2):139-155.e10. doi: 10.1016/j.ccell.2019.06.009. Epub 2019 Jul 18.
3
Role of ALDH1A1 and HTRA2 expression in CCL2/CCR2-mediated breast cancer cell growth and invasion.
Senescent macrophages in cancer: roles in tumor progression and treatment opportunities.
癌症中的衰老巨噬细胞:在肿瘤进展中的作用及治疗机会
Cancer Biol Med. 2025 May 6;22(5):439-59. doi: 10.20892/j.issn.2095-3941.2024.0589.
4
Tumor secretome shapes the immune landscape during cancer progression.肿瘤分泌组在癌症进展过程中塑造免疫格局。
J Exp Clin Cancer Res. 2025 Feb 10;44(1):47. doi: 10.1186/s13046-025-03302-0.
5
Development and validation of a prognostic prediction model for endometrial cancer based on CD8+ T cell infiltration-related genes.基于CD8 + T细胞浸润相关基因的子宫内膜癌预后预测模型的建立与验证
Medicine (Baltimore). 2024 Dec 6;103(49):e40820. doi: 10.1097/MD.0000000000040820.
6
LINC00330/CCL2 axis-mediated ESCC TAM reprogramming affects tumor progression.LINC00330/CCL2 轴介导的 ESCC TAM 重编程影响肿瘤进展。
Cell Mol Biol Lett. 2024 May 20;29(1):77. doi: 10.1186/s11658-024-00592-8.
7
DEP domain containing 1 as a biomarker for poor prognosis in lung adenocarcinoma.含DEP结构域蛋白1作为肺腺癌预后不良的生物标志物。
Heliyon. 2024 May 3;10(9):e30642. doi: 10.1016/j.heliyon.2024.e30642. eCollection 2024 May 15.
8
Placenta: an old organ with new functions.胎盘:一个具有新功能的古老器官。
Front Immunol. 2024 Apr 19;15:1385762. doi: 10.3389/fimmu.2024.1385762. eCollection 2024.
9
Predictive value of CCL2 in the prognosis and immunotherapy response of glioblastoma multiforme.CCL2 在胶质母细胞瘤预后和免疫治疗反应中的预测价值。
BMC Genomics. 2023 Dec 6;24(1):746. doi: 10.1186/s12864-023-09674-x.
10
Tumor cell-induced platelet aggregation accelerates hematogenous metastasis of malignant melanoma by triggering macrophage recruitment.肿瘤细胞诱导的血小板聚集通过触发巨噬细胞募集加速恶性黑色素瘤的血行转移。
J Exp Clin Cancer Res. 2023 Oct 23;42(1):277. doi: 10.1186/s13046-023-02856-1.
醛脱氢酶1A1(ALDH1A1)和丝氨酸蛋白酶2(HTRA2)的表达在CCL2/CCR2介导的乳腺癌细胞生长和侵袭中的作用
Biol Open. 2019 Jun 28;8(7):bio040873. doi: 10.1242/bio.040873.
4
Retinoblastoma Inactivation Induces a Protumoral Microenvironment via Enhanced CCL2 Secretion.视网膜母细胞瘤失活通过增强 CCL2 分泌诱导促肿瘤微环境。
Cancer Res. 2019 Aug 1;79(15):3903-3915. doi: 10.1158/0008-5472.CAN-18-3604. Epub 2019 Jun 12.
5
Control of tumor-associated macrophages and T cells in glioblastoma via AHR and CD39.通过 AHR 和 CD39 控制胶质母细胞瘤中的肿瘤相关巨噬细胞和 T 细胞。
Nat Neurosci. 2019 May;22(5):729-740. doi: 10.1038/s41593-019-0370-y. Epub 2019 Apr 8.
6
Targeting Tumor-Associated Macrophages in Cancer.靶向肿瘤相关巨噬细胞治疗癌症。
Trends Immunol. 2019 Apr;40(4):310-327. doi: 10.1016/j.it.2019.02.003. Epub 2019 Mar 17.
7
Monocyte heterogeneity and functions in cancer.单核细胞异质性及其在癌症中的功能。
J Leukoc Biol. 2019 Aug;106(2):309-322. doi: 10.1002/JLB.4RI0818-311R. Epub 2019 Feb 18.
8
Spatial and temporal heterogeneity of mouse and human microglia at single-cell resolution.单细胞分辨率下的小鼠和人类小胶质细胞的时空异质性。
Nature. 2019 Feb;566(7744):388-392. doi: 10.1038/s41586-019-0924-x. Epub 2019 Feb 13.
9
Chemotherapy elicits pro-metastatic extracellular vesicles in breast cancer models.化疗在乳腺癌模型中诱导促转移细胞外囊泡。
Nat Cell Biol. 2019 Feb;21(2):190-202. doi: 10.1038/s41556-018-0256-3. Epub 2018 Dec 31.
10
CCL2 Is a Vascular Permeability Factor Inducing CCR2-Dependent Endothelial Retraction during Lung Metastasis.CCL2 是一种血管通透性因子,可诱导 CCR2 依赖性内皮细胞回缩,从而促进肺部转移。
Mol Cancer Res. 2019 Mar;17(3):783-793. doi: 10.1158/1541-7786.MCR-18-0530. Epub 2018 Dec 14.